The triglyceride-glucose index (TyG index) is gaining attention as a low-cost, high-impact tool for identifying insulin resistance—an early predictor of cardiovascular disease and type 2 diabetes. This blog explores how community pharmacists can incorporate this simple screening tool into patient care, even in fast-paced or resource-limited settings. Learn why the TyG index may outperform traditional methods like HOMA-IR, how it's calculated, and what implementation could look like in practice. As pharmacists expand their role in preventative care, tools like the TyG index offer a practical way to intervene earlier and improve long-term outcomes.

Enroll in Ceuticon’s Workplace Mastery Course and master communication, productivity, and professionalism for pharmaceutical and life sciences careers.

Stay current with the 2025 ACS treatment guideline updates from the American College of Cardiology and American Heart Association. This blog breaks down key changes in pharmacologic strategies, percutaneous coronary intervention (PCI) recommendations, and secondary prevention protocols. Whether you’re in clinical practice, training, or industry, this clear and accessible overview helps you translate the latest evidence into real-world decision-making.